Ironwood Pharmaceuticals Inc financial data

Symbol
IRWD on Nasdaq
Location
100 Summer Street, Suite 2300, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 144 % +12.4%
Return On Equity -9.46 % -1357%
Return On Assets 8.06 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 163M shares +1.66%
Common Stock, Shares, Outstanding 163M shares +1.66%
Entity Public Float 917M USD -37.4%
Common Stock, Value, Issued 163K USD +1.88%
Weighted Average Number of Shares Outstanding, Basic 162M shares +1.57%
Weighted Average Number of Shares Outstanding, Diluted 178M shares +10.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 339M USD -10.4%
Research and Development Expense 98.7M USD -18.9%
Costs and Expenses 216M USD -22.7%
Operating Income (Loss) 123M USD +24.2%
Nonoperating Income (Expense) -29.6M USD -7.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 93.6M USD +30.7%
Income Tax Expense (Benefit) 65M USD -12.9%
Net Income (Loss) Attributable to Parent 28.5M USD +999%
Earnings Per Share, Basic 0 USD/shares +1150%
Earnings Per Share, Diluted 0 USD/shares +1050%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 140M USD +59.2%
Accounts Receivable, after Allowance for Credit Loss, Current 120M USD +58%
Assets, Current 274M USD +53.3%
Deferred Income Tax Assets, Net 102M USD -45.1%
Property, Plant and Equipment, Net 3.67M USD -23.5%
Operating Lease, Right-of-Use Asset 9.78M USD -14.5%
Other Assets, Noncurrent 4.84M USD -22.9%
Assets 396M USD +1.68%
Accounts Payable, Current 1.61M USD -50.2%
Employee-related Liabilities, Current 10.6M USD -31.4%
Contract with Customer, Liability, Current 1.05M USD -44.8%
Liabilities, Current 243M USD +391%
Operating Lease, Liability, Noncurrent 10.5M USD -18.5%
Other Liabilities, Noncurrent 22.2M USD -44.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.71M USD +16.5%
Retained Earnings (Accumulated Deficit) -1.67B USD +1.68%
Stockholders' Equity Attributable to Parent -264M USD +15.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -264M USD +15.2%
Liabilities and Equity 396M USD +1.68%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 20M USD -55.6%
Net Cash Provided by (Used in) Financing Activities -15.6M USD -491%
Net Cash Provided by (Used in) Investing Activities -31K USD +54.4%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 163M shares +1.66%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 19.9M USD -32.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 140M USD +59.2%
Deferred Tax Assets, Valuation Allowance 106M USD +24.1%
Deferred Tax Assets, Gross 254M USD -15.7%
Operating Lease, Liability 13.7M USD -14.5%
Depreciation 479K USD -6.63%
Payments to Acquire Property, Plant, and Equipment 31K USD -54.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 28.9M USD +1857%
Lessee, Operating Lease, Liability, to be Paid 15.7M USD -16.9%
Property, Plant and Equipment, Gross 12.9M USD -11.2%
Operating Lease, Liability, Current 3.24M USD +1.99%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.32M USD +2%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.25M USD +1.98%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.92M USD -30.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.38M USD +2.02%
Deferred Tax Assets, Operating Loss Carryforwards 147M USD +39.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 75M shares 0%
Unrecognized Tax Benefits 11.6M USD -88.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.45M USD +1.98%
Operating Lease, Payments 788K USD +1.94%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 18M USD -47.1%
Interest Expense 27.3M USD +303%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%